This retrospective, observational, single-center study was approved by the National
Commission for Research Ethics, with a waiver of informed consent.
All patients who underwent chest computed tomography (CT) for suspected
SARS-CoV-2 infection and had a reverse transcription polymerase chain reaction
(RT-PCR) test collected on the same day between February and
March 2020 at a cancer center were included.